Skip to main content
Premium Trial:

Request an Annual Quote

IntegraGen Inks DNA Chip Deal with LNCC

NEW YORK, Dec. 20 (GenomeWeb News) - IntegraGen said today that it has signed a contract to develop, manufacture, and supply DNA chips to La Ligue Nationale Contre le Cancer.


The chips, said IntegraGen, will be used for the LNCC's Cartes d'Identité des Tumeurs project, which is developing profiles of all genetic, molecular, or functional characteristics of tumor cells.


Additional terms of the arrangement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.